Published research on TB-500 / Thymosin beta-4: record counts, recent publications, reviews and registered studies, pulled from PubMed and ClinicalTrials.gov. Part of tissue repair research.
Ask TinaTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Registered studies by status: 2 recruiting, 0 active not recruiting, 11 completed.
Number of PubMed records mentioning TB-500 / Thymosin beta-4, 2016 to 2026 (2026 is year to date).
Most recently started of 18 ClinicalTrials.gov entries.
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial InfarctionNCT07586865 · Not Yet Recruiting · Phase 2 · started 2026-05-18TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVDNCT07487363 · Recruiting · Phase 1 / Phase 2 · started 2026-02-05Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2NCT05555589 · Recruiting · Phase 3 · started 2023-04-11Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial InfarctionNCT05984134 · Completed · Phase 2 · started 2022-07-15Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.InfarctionNCT05485818 · Completed · Phase 2 · started 2020-11-23A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial InfarctionNCT01311518 · Withdrawn · Phase 2 · started 2019-07Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3NCT03937882 · Completed · Phase 3 · started 2019-05-24A Phase 1b Study of Thymosin Beta 4 in Healthy VolunteersNCT04555850 · Completed · Phase 1 · started 2018-07-30A Phase 1a Study of Thymosin Beta 4 in Healthy VolunteersNCT04555824 · Completed · Phase 1 · started 2017-07-17Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2NCT02974907 · Completed · Phase 3 · started 2016-11Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1NCT02597803 · Completed · Phase 2 / Phase 3 · started 2015-09Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry EyeNCT01387347 · Completed · Phase 2 · started 2011-08Primary data for your own interpretation: published studies and regulator documents. No publisher opinion pieces.
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.Sports Med · 2026 Apr 12 · Mendias CL et al. · PubMedDangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.Mo Med · 2026 Jul-Aug · Moiz A et al. · PubMedSynthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards.Int J Pharm Compd · 2026 Jul-Aug · Willis J et al. · PubMedEquine Doping Controls of Thymosin β 4: A Population Study and Strategy for Misuse Detection.Drug Test Anal · 2024 Sep 24 · Delcourt V et al. · PubMedThymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing.Ann N Y Acad Sci · 2007 May 10 · Guarnera G et al. · PubMedAsk Tina for links to further coverageTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Third-party links, listed for reference. Educational information only, not medical advice. Hypnotic Dose does not endorse any product.